What happens when patients suddenly stop their medications? We study the health
consequences of drug interruptions caused by large, abrupt, and arbitrary changes in price …

To quantify the tracking of apolipoprotein B (apoB) levels from childhood and adolescence
and compare the tracking of apoB with low-density lipoprotein (LDL) cholesterol, a …

This systematic review aimed to gather data on the effects of sumac supplementation on
lipid profile. A systematic literature search was carried out using electronic databases …

Abstract Aims Systematic Coronary Risk Evaluation Model 2 (SCORE2) was recently
developed to predict atherosclerotic cardiovascular disease (ASCVD) in Europe. Whether …

Background Childhood cancer survivors have increased risk of dyslipidemia and
atherosclerotic cardiovascular disease (CVD). The aim of this study was to evaluate the …

Importance Elevated non–high-density lipoprotein cholesterol (non–HDL-C; a
recommended measure of lipid-related cardiovascular risk) is common in children and …

Background Statins are highly effective for primary prevention of atherosclerotic
cardiovascular disease (ASCVD) and mortality. Data on the benefit of statins in adults with …

Exploration of medicines for efficient and safe management of metabolic‐associated fatty
liver disease (MAFLD) remains a challenge. Obeticholic acid (OCA), a selective farnesoid X …

Atherosclerosis can cause severe cardiovascular disease, which is usually diagnosed in
late stages with life‐threatening complications. The lack of obvious symptoms limits its early …

Cardiovascular disease remains highly prevalent in the United States and remains the
number one cause of death. 1 Widely disseminated evidence-based clinical practice …